Advertisement
Screener

BioLife Solutions, Inc. (BLFS) Payments to Acquire Equity Method Investments

2.8 / 5 stars · 68/120 Roast Me

BioLife Solutions, Inc. Payments to Acquire Equity Method Investments

BioLife Solutions, Inc. (BLFS) reported Payments to Acquire Equity Method Investments of $6.00 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-05-15.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireEquityMethodInvestments · last filed 2020-05-15

  • BioLife Solutions, Inc. payments to acquire equity method investments for the quarter ending 2018-12-31 was $0.00.
  • BioLife Solutions, Inc. payments to acquire equity method investments for fiscal 2018 was $6.00M.
Period endPayments to Acquire Equity Method Investments 3 monthPayments to Acquire Equity Method Investments 9 monthPayments to Acquire Equity Method Investments 12 month
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-15
$6.00M
10-K · filed 2020-05-15
2018-09-30$6.00M
10-Q · filed 2019-11-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Axogen, Inc. (AXGN)United States$2.329B-73.83
CONMED Corp (CNMD)United States$1.353B26.72
Ceribell, Inc. (CBLL)United States$0.916B-11.27
TransMedics Group, Inc. (TMDX)United States$2.911B15.17
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Vivani Medical, Inc. (VANI)United States$0.111B
electroCore, Inc. (ECOR)United States$0.102B